Ipilimumab-Induced Hypophysitis: A Detailed Longitudinal Analysis in a Large Cohort of Patients With Metastatic MelanomaAlexander T. Faje, Lisa B. Nachtigall, Riley Fadden et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 483
High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanomaAlexander T. Faje, Ryan J. Sullivan, Donald P. Lawrence et al.|Cancer|2018Cited by 481